Last reviewed · How we verify
Urinary tract infectious disease
Approved treatments
- MEZLOCILLIN
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Furagin
Furagin works by inhibiting bacterial growth and replication, specifically targeting the bacterial enzyme responsible for DNA synthesis. - Eryped · Arbor Pharms Llc
- Cefradex · Bristol-Myers Squibb
- Cefaprin · Bristol-Myers Squibb
- Amoxycillin · King George's Medical University
- Osmoprep · Salix Pharms
- Unasyn · Bristol-Myers Squibb
- Azo Gantrisin · Alra
- Trimethoprim · Dr Reddys Labs Sa
- Ceclor
- Amygdalic Acid
Amygdalic Acid works by inhibiting bacterial growth and replication in the urinary tract. - Abelcet · Astellas Pharma
- Demethylchlortetracycline · Pfizer
- Pipracil
Pipracil works by inhibiting bacterial cell wall synthesis, ultimately leading to cell lysis and death. - Amoxil · Generic (originally Beecham/GSK)
Broad-spectrum aminopenicillin that inhibits bacterial cell wall synthesis by binding penicillin-binding proteins. - Lithostat · Mission Pharma
- Cefadole
Cefadole works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - ALATROFLOXACIN · Pfizer
- Meclan · Johnson And Johnson
- Ciclacillin · Pfizer
- Cortisporin · Pfizer
- Gracevit · Daiichi Sankyo
- Carampicillin
- Urfadine
Urfadine works by inhibiting the growth and replication of bacteria in the urinary tract. - Azactam · Bristol-Myers Squibb
Aztreonam inhibits bacterial cell wall synthesis, acting as a bactericidal agent. - Hiprex · Esjay Pharma
- Cortisporin · Pfizer
- Zerbaxa · Cubist Pharms
Zerbaxa works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Monocid
- Cefadrox
- AZLOCILLIN · Bayer Pharmaceuticals Corp
- Recarbrio · Merck & Co.
Recarbrio works by inhibiting the beta-lactamase enzymes produced by certain bacteria, allowing carbapenem antibiotics to effectively target and kill the bacteria. - Cephalotin · Eli Lilly
- TICARCILLIN
- Enoksetin
- Ticarcillin
- Kanacin · Bristol-Myers Squibb
- Augmentin 250 · Dr Reddys Labs Inc
- Fetroja · Shionogi
Fetroja works by binding to penicillin-binding proteins on bacterial cell walls, inhibiting cell wall synthesis and ultimately leading to bacterial cell death. - Noroxin
- Floxin
- Epocelin
- Zefazone
- Carboxybenzylpenicillin
- Minocycline Hydrochloride · Rempex
MINOCYCLINE works by inhibiting protein synthesis in bacteria, ultimately leading to their death. - Monurol · Zambon Spa
- Cinobac · Eli Lilly
- Suprax
Suprax works by inhibiting the bacterial enzyme 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1, disrupting bacterial cell wall synthesis.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Urinary tract infectious disease patent landscape — cliff calendar, originator estates, attackable patents
- Urinary tract infectious disease treatment landscape brief
- Urinary tract infectious disease treatment updates RSS
Frequently asked questions about Urinary tract infectious disease
What drugs treat Urinary tract infectious disease?
Tracked treatments include MEZLOCILLIN, Ramycin, Furagin, Eryped, Cefradex, Cefaprin, Amoxycillin, Osmoprep.
What is the treatment for Urinary tract infectious disease?
Standard treatment for Urinary tract infectious disease includes MEZLOCILLIN, Ramycin, Furagin, Eryped, Cefradex. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Urinary tract infectious disease patent cliff · Urinary tract infectious disease CI report
- Treatment: MEZLOCILLIN
- Treatment: Ramycin
- Treatment: Furagin
- Treatment: Eryped · Arbor Pharms Llc
- Treatment: Cefradex · Bristol-Myers Squibb
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing